Fate Therapeutics, Inc. FATE was a big mover last session, as its shares rose almost 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally breaks the recent trend for the company, as the stock is now trading above the volatile price range of $1.67 to $1.87 in the past one-month time frame.
Over the last 30 days, the company did not witness any estimate revision while the Zacks Consensus Estimate moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Fate Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
FATE THERAPEUTC Price
FATE THERAPEUTC Price | FATE THERAPEUTC Quote
A better-ranked biomedical stock is ANI Pharmaceuticals, Inc. ANIP with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
FATE THERAPEUTC (FATE): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research